← Back to Search

Low-level Laser Therapy

Effect of the Erchonia® HLS™ for the Relief of Tinnitus Symptoms

N/A
Waitlist Available
Research Sponsored by Erchonia Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 8 week
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if a special red light can help reduce the ringing in the ears for adults with tinnitus. The light might work by calming nerves or reducing inflammation.

Eligible Conditions
  • Tinnitus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 8 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 8 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Total Score on the Tinnitus Handicap Inventory (THI).

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Erchonia HLSExperimental Treatment1 Intervention
635 nanometers (nm) laser application

Find a Location

Who is running the clinical trial?

Erchonia CorporationLead Sponsor
44 Previous Clinical Trials
2,064 Total Patients Enrolled
2 Trials studying Tinnitus
41 Patients Enrolled for Tinnitus
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top